Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Free Cash Flow (2017 - 2025)

Inspire Medical Systems' Free Cash Flow history spans 9 years, with the latest figure at $41.8 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 32.73% year-over-year to $41.8 million; the TTM value through Dec 2025 reached $78.5 million, down 13.88%, while the annual FY2025 figure was $78.5 million, 13.88% down from the prior year.
  • Free Cash Flow for Q4 2025 was $41.8 million at Inspire Medical Systems, down from $46.5 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $62.2 million in Q4 2024 and bottomed at -$15.1 million in Q1 2025.
  • The 5-year median for Free Cash Flow is $2.4 million (2021), against an average of $7.6 million.
  • The largest annual shift saw Free Cash Flow skyrocketed 2270.94% in 2024 before it plummeted 432.79% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at $1.1 million in 2021, then surged by 929.99% to $11.5 million in 2022, then plummeted by 124.88% to -$2.9 million in 2023, then surged by 2270.94% to $62.2 million in 2024, then plummeted by 32.73% to $41.8 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Free Cash Flow are $41.8 million (Q4 2025), $46.5 million (Q3 2025), and $5.3 million (Q2 2025).